Credit Suisse’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.17M | Buy |
57,435
+94
| +0.2% | +$6.29K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $3.51M | Buy |
57,341
+4,865
| +9% | +$289K | ﹤0.01% | 1541 |
|
|
2023
Q3 | $3M | Sell |
52,476
-5,951
| -10% | -$360K | ﹤0.01% | 1576 |
|
|
2023
Q2 | $3.47M | Buy |
58,427
+14,197
| +32% | +$850K | ﹤0.01% | 1573 |
|
|
2023
Q1 | $2.77M | Buy |
44,230
+1,181
| +3% | +$73.7K | ﹤0.01% | 1682 |
|
|
2022
Q4 | $2.69M | Sell |
43,049
-245
| -0.6% | -$14K | ﹤0.01% | 1713 |
|
|
2022
Q3 | $2.16M | Buy |
43,294
+959
| +2% | +$53.1K | ﹤0.01% | 1806 |
|
|
2022
Q2 | $2.49M | Sell |
42,335
-5,823
| -12% | -$321K | ﹤0.01% | 1757 |
|
|
2022
Q1 | $2.55M | Buy |
48,158
+1,896
| +4% | +$109K | ﹤0.01% | 1920 |
|
|
2021
Q4 | $2.81M | Sell |
46,262
-474
| -1% | -$28.1K | ﹤0.01% | 2513 |
|
|
2021
Q3 | $2.62M | Sell |
46,736
-2,915
| -6% | -$160K | ﹤0.01% | 2607 |
|
|
2021
Q2 | $2.59M | Sell |
49,651
-6,805
| -12% | -$327K | ﹤0.01% | 2641 |
|
|
2021
Q1 | $2.49M | Sell |
56,456
-17,272
| -23% | -$726K | ﹤0.01% | 2650 |
|
|
2020
Q4 | $2.57M | Buy |
73,728
+29,978
| +69% | +$1.06M | ﹤0.01% | 2634 |
|
|
2020
Q3 | $1.59M | Sell |
43,750
-10,715
| -20% | -$398K | ﹤0.01% | 2594 |
|
|
2020
Q2 | $2.04M | Buy |
54,465
+10,426
| +24% | +$417K | ﹤0.01% | 2366 |
|
|
2020
Q1 | $1.62M | Sell |
44,039
-8,259
| -16% | -$321K | ﹤0.01% | 2282 |
|
|
2019
Q4 | $2.12M | Sell |
52,298
-25,564
| -33% | -$954K | ﹤0.01% | 2556 |
|
|
2019
Q3 | $2.7M | Sell |
77,862
-46,789
| -38% | -$1.54M | ﹤0.01% | 2252 |
|
|
2019
Q2 | $3.95M | Buy |
124,651
+36,268
| +41% | +$1.08M | ﹤0.01% | 1932 |
|
|
2019
Q1 | $2.64M | Sell |
88,383
-51,827
| -37% | -$1.49M | ﹤0.01% | 2162 |
|
|
2018
Q4 | $4.33M | Buy |
140,210
+81,673
| +140% | +$2.98M | ﹤0.01% | 1673 |
|
|
2018
Q3 | $2.22M | Sell |
58,537
-6,629
| -10% | -$251K | ﹤0.01% | 2278 |
|
|
2018
Q2 | $2.5M | Sell |
65,166
-78
| -0.1% | -$2.63K | ﹤0.01% | 2267 |
|
|
2018
Q1 | $2.2M | Sell |
65,244
-5,684
| -8% | -$218K | ﹤0.01% | 2332 |
|
|
2017
Q4 | $3.15M | Sell |
70,928
-13,570
| -16% | -$618K | ﹤0.01% | 2100 |
|
|
2017
Q3 | $4.23M | Buy |
84,498
+36,320
| +75% | +$1.86M | ﹤0.01% | 1903 |
|
|
2017
Q2 | $2.54M | Sell |
48,178
-4,559
| -9% | -$244K | ﹤0.01% | 2073 |
|
|
2017
Q1 | $2.93M | Sell |
52,737
-9,475
| -15% | -$523K | ﹤0.01% | 2065 |
|
|
2016
Q4 | $3.24M | Sell |
62,212
-6,018
| -9% | -$290K | ﹤0.01% | 2023 |
|
|
2016
Q3 | $3.29M | Sell |
68,230
-57,666
| -46% | -$2.92M | ﹤0.01% | 1987 |
|
|
2016
Q2 | $6.97M | Buy |
125,896
+83,546
| +197% | +$4.6M | 0.01% | 1403 |
|
|
2016
Q1 | $2.26M | Sell |
42,350
-42,860
| -50% | -$2.11M | ﹤0.01% | 2108 |
|
|
2015
Q4 | $4.39M | Buy |
85,210
+2,410
| +3% | +$120K | 0.01% | 1687 |
|
|
2015
Q3 | $3.74M | Sell |
82,800
-883
| -1% | -$41.7K | ﹤0.01% | 1778 |
|
|
2015
Q2 | $3.87M | Sell |
83,683
-3,613
| -4% | -$158K | ﹤0.01% | 1960 |
|
|
2015
Q1 | $3.74M | Buy |
87,296
+16,082
| +23% | +$613K | ﹤0.01% | 1898 |
|
|
2014
Q4 | $2.47M | Sell |
71,214
-14,931
| -17% | -$495K | ﹤0.01% | 2364 |
|
|
2014
Q3 | $2.79M | Buy |
86,145
+27,662
| +47% | +$925K | ﹤0.01% | 2218 |
|
|
2014
Q2 | $1.98M | Sell |
58,483
-25,666
| -31% | -$822K | ﹤0.01% | 2725 |
|
|
2014
Q1 | $2.29M | Buy |
84,149
+13,485
| +19% | +$401K | ﹤0.01% | 2405 |
|
|
2013
Q4 | $2.53M | Sell |
70,664
-42,816
| -38% | -$1.42M | ﹤0.01% | 2450 |
|
|
2013
Q3 | $3.42M | Buy |
113,480
+33,197
| +41% | +$1.09M | ﹤0.01% | 1943 |
|
|
2013
Q2 | $2.34M | Buy |
+80,283
| New | +$2.26M | ﹤0.01% | 2153 |
|
Other funds holding PBH
AI
Credit Suisse's PBH Position: Q1 2024 in Review
Credit Suisse increased its Prestige Consumer Healthcare (PBH) stake by 0.16% in Q1 2024, buying an estimated $6.29K and bringing the position to 57,435 shares worth $4.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1395.
Credit Suisse first reported a position in PBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $6.97M in Q2 2016. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.
- Credit Suisse held 57,435 shares of Prestige Consumer Healthcare worth $4.17M as of Q1 2024.
- Credit Suisse bought 94 Prestige Consumer Healthcare shares in Q1 2024, an estimated $6.29K.
- Prestige Consumer Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1395 holding.
- Credit Suisse first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Prestige Consumer Healthcare position peaked at $6.97M in Q2 2016.
- 312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.